These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 23681013)
1. Peripheral blood miR-328 expression as a potential biomarker for the early diagnosis of NSCLC. Ulivi P; Foschi G; Mengozzi M; Scarpi E; Silvestrini R; Amadori D; Zoli W Int J Mol Sci; 2013 May; 14(5):10332-42. PubMed ID: 23681013 [TBL] [Abstract][Full Text] [Related]
2. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer. Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145 [TBL] [Abstract][Full Text] [Related]
3. Potential circulating miRNA signature for early detection of NSCLC. Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589 [TBL] [Abstract][Full Text] [Related]
4. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer. Shi GL; Chen Y; Sun Y; Yin YJ; Song CX Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492 [TBL] [Abstract][Full Text] [Related]
5. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252 [TBL] [Abstract][Full Text] [Related]
6. Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors. Roth C; Stückrath I; Pantel K; Izbicki JR; Tachezy M; Schwarzenbach H PLoS One; 2012; 7(6):e38248. PubMed ID: 22675530 [TBL] [Abstract][Full Text] [Related]
7. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer. Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer. Zhu W; Zhou K; Zha Y; Chen D; He J; Ma H; Liu X; Le H; Zhang Y PLoS One; 2016; 11(4):e0153046. PubMed ID: 27093275 [TBL] [Abstract][Full Text] [Related]
9. Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer. Wang RJ; Zheng YH; Wang P; Zhang JZ Int J Clin Exp Pathol; 2015; 8(1):765-71. PubMed ID: 25755772 [TBL] [Abstract][Full Text] [Related]
10. Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer. Guo W; Zhang Y; Zhang Y; Shi Y; Xi J; Fan H; Xu S Int J Mol Med; 2015 Dec; 36(6):1720-6. PubMed ID: 26497897 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer. Li W; Wang Y; Zhang Q; Tang L; Liu X; Dai Y; Xiao L; Huang S; Chen L; Guo Z; Lu J; Yuan K PLoS One; 2015; 10(8):e0134220. PubMed ID: 26237047 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of serum miR-25 in non-small-cell lung cancer. Li J; Yu M; Liu Z; Liu B Br J Biomed Sci; 2019 Jul; 76(3):111-116. PubMed ID: 30919763 [No Abstract] [Full Text] [Related]
13. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer. Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472 [TBL] [Abstract][Full Text] [Related]
14. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer. Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956 [TBL] [Abstract][Full Text] [Related]
15. Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer. Trakunram K; Chaniad P; Geater SL; Keeratichananont W; Chittithavorn V; Uttayamakul S; Buya S; Raungrut P; Thongsuksai P Cancer Biol Med; 2020 Aug; 17(3):652-663. PubMed ID: 32944397 [No Abstract] [Full Text] [Related]
16. Discovery and validation of extracellular vesicle-associated miRNAs as noninvasive detection biomarkers for early-stage non-small-cell lung cancer. Zhong Y; Ding X; Bian Y; Wang J; Zhou W; Wang X; Li P; Shen Y; Wang JJ; Li J; Zhang C; Wang C Mol Oncol; 2021 Sep; 15(9):2439-2452. PubMed ID: 33340250 [TBL] [Abstract][Full Text] [Related]
17. Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients. Zhang J; Wang T; Zhang Y; Wang H; Wu Y; Liu K; Pei C Cancer Biomark; 2018; 21(4):763-768. PubMed ID: 29286916 [TBL] [Abstract][Full Text] [Related]
18. Plasma miR-1247-5p, miR-301b-3p and miR-105-5p as potential biomarkers for early diagnosis of non-small cell lung cancer. Dong X; Chang M; Song X; Ding S; Xie L; Song X Thorac Cancer; 2021 Feb; 12(4):539-548. PubMed ID: 33372399 [TBL] [Abstract][Full Text] [Related]
19. Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer. Yang X; Zhang Q; Zhang M; Su W; Wang Z; Li Y; Zhang J; Beer DG; Yang S; Chen G Int J Biol Sci; 2019; 15(8):1712-1722. PubMed ID: 31360113 [TBL] [Abstract][Full Text] [Related]
20. Serum miR-223: A Validated Biomarker for Detection of Early-Stage Non-Small Cell Lung Cancer. D'Antona P; Cattoni M; Dominioni L; Poli A; Moretti F; Cinquetti R; Gini E; Daffrè E; Noonan DM; Imperatori A; Rotolo N; Campomenosi P Cancer Epidemiol Biomarkers Prev; 2019 Nov; 28(11):1926-1933. PubMed ID: 31488416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]